Open Accessibility Menu

Neurosurgery

About Us

Our doctors provide state-of-the-art medicine in the treatment and management of neurological disorders, including brain and spinal tumors, degenerative spinal conditions, epilepsy, movement disorders, cerebrovascular disorders such as stroke and aneurysm, and pain.

Procedures include minimally invasive surgical techniques for the brain and spine, deep brain stimulation for the treatment of both movement (e.g. Parkinson’s) and mood disorders, awake craniotomy techniques for mapping brain function, radiosurgery (stereotactic approaches and whole brain), carotid artery stenting, and minimally invasive treatment of brain aneurysm (coiling).

General Neurosurgery

General neurosurgery covers a large number of procedures, including traditional open surgeries to remove brain tumors, relieve cranial pressure, treat traumatic brain injury, or correct malformations of blood vessels.

Learn About Our Services:

Conveniently Located

Clinical Trials

  • Responsive Neurostimulator System (RNS) Long Term Treatment Investigation
    This study is designed to assess the ongoing safety and to evaluate the long-term effectiveness of adjunctive RNS therapy in reducing seizures that are refractory to two or more antiepileptic medications.
  • Malignant Brain Tumors
    A Multicenter Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor in Patients with Newly Diagnosed or Recurrent Malignant Gliomas: A Safety, Histopathology, and Correlative Biomarker Study This single arm trial is being conducted to establish the safety and efficacy of Gliolan® (5-ALA) in patients undergoing resection of newly diagnosed or recurrent malignant gliomas. The rationale for the study is that Gliolan® (5-ALA), as an adjunct to tumor resection, is safe and will provide surgeons with real-time visualization of malignant tumor.
  • DuraSeal Exact Spine Sealant System Post-Approval Study
    This multi-center, non-randomized, two-arm, Post Approval Study will further evaluate the rate of postoperative CSF leaks in subjects who undergo a spinal procedure and receive DuraSeal Exact Spine Sealant for treatment of either an intentional or incidental opening of the dura compared to Control patients who receive other products and/or treatments to close the .dura. Subjects must be 18 years of age or older and have had a spinal procedure where a dural opening (whether intentional or incidental) occurred and was treated with either: -DuraSeal Exact Spine Sealant System (DuraSeal Sealant arm ONLY) or- Any other method of sealing the dura with the exception of DuraSeal Sealant- either spinal or cranial (Control arm ONLY)
  • Controlled Trial of Deep Brain Stimulation (DBS) for Obsessive Compulsive Disorder (OCD)
    The goal of this study is to complete the first definitive controlled trial of a neurosurgical procedure for a severe psychiatric illness. The study will compare the effects of three months of double-masked placebo versus active DBS on OCD severity. Potential participants must:-be between the ages of 18 and 75-have OCD diagnosed by Structured Clinical Interview for DSM-IV (SCID-IV)-have persistence of sever symptoms and impairment for five years or more despite at least three first-line and two second-line treatments.
  • Acromegaly Safety Monitoring Program
    An Acromegaly Safety Monitoring Program for Treating Patients with Pasireotide LAR who are in need of Medical Therapy (ACCESS Study)This study will provide acromegalic patients, for whom medical therapy is appropriate, access to paseriotide LAR while regulatory approval is sought. Potential patients must:-be age 18 or older-have confirmed diagnosis of active acromegaly (caused by GH producing pituitary tumor)-not be controlled by pituitary surgery or not be eligible or refuse surgery.